secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ginkgo Bioworks Holdings, Inc. (DNA)
CIK:        0001830214
Form:       8-K/A
Filed at:   2024-06-24T23:59:59+00:00
Accession:  0001628280-24-029635
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Ginkgo Bioworks expands restructuring: at least 35% workforce reduction, $12M+ severance costs
--------------------------------------------------------------------------------

- Workforce reduction expanded from 25% labor expense cut to 35% headcount reduction; implementation began June 17, 2024.
- Expected cash costs of at least $12 million in severance and related separation costs for initial June reductions.
- Substantially completed in 2025, subject to local laws; total costs not yet estimated.
- Facility consolidation also planned as part of multi-year cost reduction plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1830214/000162828024029635/0001628280-24-029635-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1830214/000162828024029635/dna-20240509.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-029635

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer